In the News


ACP launches identity campaign celebrating depth, diversity of internal medicine physicians

The multiyear campaign will emphasize that internal medicine physicians are experts in complexity and brilliant connectors for our patients and health care systems, among other assets.

App-enabled device no better than standard device for self-measuring blood pressure

A smartphone app did not provide any additional reduction in blood pressure, and patients with hypertension would recommend a standard device as much as they would the app-connected device, a study concluded.

MKSAP Quiz: 6-month history of intermittent claudication

A 68-year-old man is evaluated for a 6-month history of intermittent claudication. His symptoms have been slowly progressive but are not life limiting. Medical history is significant for hypertension, hyperlipidemia, and carotid artery stenosis treated with left carotid endarterectomy. He is a former smoker but quit 10 years ago. Following a physical exam and lab studies, what is the most appropriate treatment to reduce this patient's cardiovascular risk?

Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine

Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.

6-food elimination diet may work for more than half of patients with eosinophilic esophagitis

Removing milk, wheat, soy, eggs, tree nuts/peanuts, and fish/shellfish from one's diet and then gradually reintroducing these food categories identified a single food trigger for 69% of participating patients with eosinophilic esophagitis, a retrospective study found.

And the winner is …

ACP Internist Weekly has tallied the voting from its latest cartoon contest, where readers are invited to match wits against their peers to provide the most original and amusing caption.